Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05543993 · ClinicalTrials.gov registry record
COVID Booster in Pregnancy and Lactation
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 150
- Enrollment target
NCT05543993 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 150 participants.
The verdict
NCT05543993 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This is a prospective longitudinal cohort study to evaluate the impact of COVID-19 vaccination and booster on maternal and infant immunity against COVID-19 variants over time.
Interventions
- DRUG Bivalent COVID-19 Booster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2024-06-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05543993
The ClinicalTrials.gov registry entry for NCT05543993 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bivalent COVID-19 Booster is the first listed.
NCT05543993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05543993 about?
NCT05543993 is a clinical study titled "COVID Booster in Pregnancy and Lactation". This is a prospective longitudinal cohort study to evaluate the impact of COVID-19 vaccination and booster on maternal and infant immunity against COVID-19 variants over time.
What is the current status of trial NCT05543993?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2022-09-29. Estimated completion is 2024-06-10.
What interventions are being tested in trial NCT05543993?
The interventions under investigation include: Bivalent COVID-19 Booster (DRUG).
Who is sponsoring clinical trial NCT05543993?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.